Thymidine phosphorylase activity and prodrug effects in a three- dimensional model of angiogenesis: Implications for the treatment of ovarian cancer

American Journal of Pathology

Volumn 153, Issue 5, 1998, Pages 1573-1578

  Stevenson, Darren Paul ^a   Collins, William Patrick ^a,c   Farzaneh, Farzin ^a   Hata, Kohkichi ^b   Miyazaki, Kohji ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SHIMANE UNIVERSITY   (Japan)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYRIBOSE; DOXIFLURIDINE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PRODRUG; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; NONHUMAN; OVARY CANCER; OVARY CYST; PRIORITY JOURNAL; RAT; TREATMENT PLANNING;

EID: 0031793889     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65745-8     Document Type: Article

References (32)

1. Folkman J, Watson K, Ingber D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339:58-61
2. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934
3. Lee WJ, Chu JS, Houng SJ, Chung MF, Wang SM, Chen KM: Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study. Ann Surg Oncol 1995, 2:246-251
4. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995, 147:33-41
5. Bourne TH, Reynolds K, Campbell S, Collins WP: Ultrasound screening for early ovarian cancer. Diagnostic Oncol 1992, 2:35-38
6. Hata K, Hata T, Kitao M: Intratumoral peak systolic velocity as a new possible predictor for detection of adnexal malignancy. Am J Obstet Gynecol 1995, 172:1496-1500
7. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R: Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994, 86:1234-1238
8. Hata K, Hata T, Collins WP: Association between the concentration of thymidine phosphorylase and ultrasound derived indices of blood flow in ovarian masses. Cancer 1997, 80:1079-1084
9. Barton GJ, Ponting CP, Spraggon G, Finnis C, Sleep D: Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase Protein Sci 1992, 1:688-690
10. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S: Angiogenic factor. Nature 1992, 356:668
11. Moghaddam A, Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and conformation of its thymidine phosphorylase activity. Biochemistry 1992, 31:12141-12146
12. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin C: Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 1992, 184:1311-1316
13. Finnis C, Dodsworth N, Pollitt CE, Carr G, Sleep D: Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 1993, 212:201-210
14. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 1993, 114:9-14
15. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin C: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989, 338:557-562
16. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S: Angiogenic activity of enzymes. Nature 1994, 368:198-199
17. Moghaddam A, Zhang H, Fan TD, Hu D, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 1995, 92:998-1002
18. Stevenson DP, Milligan SR, Collins WP: Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol 1998, 152:1641-1646
19. Fujimoto J, Wang Y, Inoue K, Ogawa M: Antitumor activity of a new fluoropyrimidine derivative, 5′-deoxy-5-fluorouridine, against murine and human experimental tumors. Jpn J Cancer 1985, 76:644-650
20. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ, Harris AL: Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 1995, 72:669-675
21. Chu E, Lai G, Zinn S, Allegra CJ: Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA. Mol Pharmacol 1990, 38:410-417
22. Nicosia RF, Ottinetti A: Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab Invest 1990, 63:115-122
23. Jaggers DC, Collins WP, Milligan SR: Potent inhibitory effects of steroids in an in vitro model of angiogenesis. J Endocrinol 1996, 150:457-464
24. Nicosia RF, Ottinetti A: Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional culture of rat aorta: a comparative study of angiogenesis in Matrigel, collagen, fibrin and plasma clot. In Vitro Cell Dev Biol 1990, 26:119-128
25. Nicosia RF, Bonanno E, Smith M: Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 1993, 154:654-661
26. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 1993, 114:9-14
27. Berne M, Gustavsson B, Almersjo O, Spears P, Sundstrom E: Inhibition of thymidylate synthase after administration of doxifluridine in a transplantable colon carcinoma in the rat. Cancer Invest 1988, 6:377-383
28. Senderoff RI, Weber PA, Smith DR, Sokoloski TD: Evaluation of antiproliferative agents using a cell-culture model. Invest Ophthalmol Vis Sci 1990, 31:2572-2578
29. Choong YS, Lee SP, Alley PA: Comparison of the pyrimidine nucleoside phosphorylase activity in human tumors and normal tissues. Exp Pathol 1988, 33:23-25
30. Armstrong RD, Diassio RB: Selective activation of 5′-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index. Cancer Res 1981, 41:4891-4894
31. Inaba M, Mitsuhashi J, Ozawa S: Kinetic analysis of 5-fluorouracil action against various cancer cells. Jpn J Cancer Res 1990, 81: 1039-1044
32. Matsuoka H, Furusawa M, Tomoda H, Seo Y, Sugimachi K: Increased cytotoxicity of 5′-deoxy-5-fluorouridine by prolonged culture with folonic acid. Anticancer Res 1993, 13:2201-2206